Community stack
GLOW Stack
GHK-Cu + BPC-157 + TB-500
Vendor and community sources market GLOW for a combined skin-and-tissue goal - faster wound and injury healing plus visible skin quality (collagen, elasticity, a 'fresher' look) - extending the Wolverine pairing's injury focus with a dermatology angle via GHK-Cu.
Community stack - not clinically tested
No clinical trial has tested this exact combination. The rationale below is built from each compound's individual research, and the dosing is community-derived. None of these compounds is FDA-approved for this use.
What is in it
Why people run it
Sources describe GLOW as covering healing in stages rather than duplicating one mechanism three times. Revolution Health ties each claim to a per-compound mechanism: BPC-157 for angiogenesis, fibroblast migration, collagen formation and lower inflammatory cytokines; TB-500 for actin production, reduced fibrosis and downregulated inflammatory pathways; GHK-Cu for collagen/elastin stimulation plus antioxidant and anti-inflammatory action. Doctor Paria's piece frames the same three roles as covering 'the full arc of healing: calming inflammation, building fresh tissue, and remodeling it for strength and flexibility.' As with Wolverine, this rationale is built by stacking each peptide's individually studied actions, not from any study of the three combined.
Community dosing
communityNo single fixed protocol dominates across the sources checked; it is generally sold as a pre-blended vial. Revolution Health cites one example composition of BPC-157 5 mg + TB-500 10 mg + GHK-Cu 27 mg in a single vial, but states actual dosing is left to individual or physician judgment rather than a published schedule. Neither source fetched gives a frequency or cycle length.
Work out your draw in the calculatorThe honest caveat
No clinical trial has tested GHK-Cu, BPC-157 and TB-500 together - neither source checked claims one exists. Revolution Health states plainly that these peptides are 'not FDA-approved for human use' and are 'intended for research purposes only.' Doctor Paria's piece, while sympathetic to the stack, still tells readers 'it's essential to work with a trusted medical provider' rather than dosing on their own.
Sources
- [1]The Glow StackDescribes GLOW's goal as 'faster healing, smoother skin, and stronger connective tissue' and frames GHK-Cu, BPC-157 and TB-500 as covering the 'full arc of healing' together; advises working with a medical provider rather than self-dosing; notes peptides are not FDA-approved for these uses.
- [2]GLOW Peptide: BPC-157 + TB-500 + GHK-Cu for Injury and Tissue RecoveryGives an example vial composition (BPC-157 5 mg, TB-500 10 mg, GHK-Cu 27 mg) and a per-compound mechanism for each peptide; states these peptides are 'not FDA-approved for human use' and 'intended for research purposes only.'
Other stacks